(R)-3-((Tetrahydrofuran-2-yl)methyl)-2-thioxo-1,2,3,9-tetrahydro-6H-purin-6-one

Catalog No. :
ACGZYB901
CAS No. :
618913-30-7
Molecular Formula :
C10H12N4O2S
Molecular Weight :
252.30

IUPAC Name:(R)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxo-1,2,3,9-tetrahydro-6H-purin-6-one

(R)-3-((Tetrahydrofuran-2-yl)methyl)-2-thioxo-1,2,3,9-tetrahydro-6H-purin-6-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$132.00Login to see priceInquiryInquiry
50mg98%$223.00Login to see priceInquiryInquiry
100mg98%$379.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-((Tetrahydrofuran-2-yl)methyl)-2-thioxo-1,2,3,9-tetrahydro-6H-purin-6-one
IUPAC Name(R)-3-((tetrahydrofuran-2-yl)methyl)-2-thioxo-1,2,3,9-tetrahydro-6H-purin-6-one
MDL No.MFCD31619279
Molecular FormulaC10H12N4O2S
Molecular Weight252.30
SMILESO=C1NC(N(C[C@@H]2OCCC2)C3=C1N=CN3)=S
InChI KeyRSPDBEVKURKEII-ZCFIWIBFSA-N
Synonym2-sulfanylidene-3-[(2R)-tetrahydro-2-furanylmethyl]-1,2,3,7-tetrahydro-6H-purin-6-one | AZD 5904 [WHO-DD] | 3-[[(2~{R})-oxolan-2-yl]methyl]-2-sulfanylidene-9~{H}-purin-6-one | 62A9CG81VN | Q27074766 | MS-23562 | 1,2,3,9-Tetrahydro-3-(((2R)-tetrahydro-2-fu
CAS No.618913-30-7
PubChem CID10264211

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACGZYB901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZYB901 route product structure diagram
    ACGZYB901618913-30-7
Inquiry

2. ACGZYB901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGZYB901 route product structure diagram
    ACGZYB901618913-30-7
Inquiry

Comments (0)